New Weight-Loss drug shows promise in early safety trial
NCT ID NCT07121153
First seen Feb 25, 2026 · Last updated Apr 24, 2026 · Updated 8 times
Summary
This early-stage study tested a new medicine called NNC0487-0111 in 36 Chinese adults who were overweight or obese. The main goal was to check if the drug is safe and how the body processes it. Participants received either the medicine or a placebo, and the study lasted up to 53 days. Results will help decide if further testing is needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jinan Central Hospital
Jinan, Shandong, 250000, China
Conditions
Explore the condition pages connected to this study.